A

AbCellera Biologics
D

ABCL

2.76000
USD
0.03
(1.10%)
Market Closed
Volume
40,362
EPS
-1
Div Yield
-
P/E
-5
Market Cap
815,210,933
Related Instruments
    AAPL
    AAPL
    -3.130
    (-1.37%)
    229.75 USD
    AMZN
    AMZN
    -8.930
    (-4.22%)
    197.06 USD
    CRM
    CRM
    -6.22
    (-1.88%)
    342.01 USD
    GOOGL
    GOOGL
    -3.110
    (-1.77%)
    164.75 USD
    MSFT
    MSFT
    -11.75
    (-2.75%)
    417.03 USD
    NFLX
    NFLX
    -13.37
    (-1.60%)
    897.775 USD
    TSLA
    TSLA
    9.69
    (3.11%)
    352.65 USD
    More
News

Title: AbCellera Biologics

Sector: Healthcare
Industry: Biotechnology
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.